CABOTEGRAVIR SODIUM

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C19H16F2N3O5.Na
Molecular Weight	427.334
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[Na+].[H][C@@]12CN3C=C(C(=O)NCC4=CC=C(F)C=C4F)C(=O)C([O-])=C3C(=O)N1[C@@H](C)CO2

InChI

InChIKey=AEZBWGMXBKPGFP-KIUAEZIZSA-M

InChI=1S/C19H17F2N3O5.Na/c1-9-8-29-14-7-23-6-12(16(25)17(26)15(23)19(28)24(9)14)18(27)22-5-10-2-3-11(20)4-13(10)21;/h2-4,6,9,14,26H,5,7-8H2,1H3,(H,22,27);/q;+1/p-1/t9-,14+;/m0./s1

HIDE SMILES / InChI

Approval Year

Name

Type

Language

CABOTEGRAVIR SODIUM

Official Name

English

Cabotegravir sodium [WHO-DD]

Common Name

English

CABOTEGRAVIR SODIUM [ORANGE BOOK]

Common Name

English

GSK1265744B

Code

English

VOCABRIA

Brand Name

English

Sodium (3S,11aR)-8-{[(2,4-difluorophenyl)methyl]carbamoyl}-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate

Systematic Name

English

GSK-1265744B

Code

English

CABOTEGRAVIR SODIUM [JAN]

Common Name

English

CABOTEGRAVIR SODIUM [USAN]

Common Name

English

S-265744B

Code

English

OXAZOLO(3,2-A)PYRIDO(1,2-D)PYRAZINE-8-CARBOXAMIDE, N-((2,4-DIFLUOROPHENYL)METHYL)-2,3,5,7,11,11A-HEXAHYDRO-6-HYDROXY-3-METHYL-5,7-DIOXO-, SODIUM SALT (1:1), (3S,11AR)-

Systematic Name

English

Code System Code Type Description

DAILYMED

3L12PT535M